Aiswarya Saravanan, Jordan Safran, Anna Loughman, Grace Lin, Shivanshi Vaid, Dana Allababidi et al. Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy. // Annals of Clinical and Translational Neurology. – 2026. – DOI: 10.1002/acn3.70500. – URL: https://onlinelibrary.wiley.com/doi/10.1002/acn3.70500?af=R
Aiswarya Saravanan, Jordan Safran, Anna Loughman, Grace Lin, Shivanshi Vaid, Dana Allababidi, Peter M. Tessier, & Louis T. Dang (2026). Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70500
Aiswarya Saravanan, et al. “Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy.” Annals of Clinical and Translational Neurology, 2026. doi:10.1002/acn3.70500.
@article{Saravanan2026,
title = {Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy},
author = {Saravanan, Aiswarya and Safran, Jordan and Loughman, Anna and Lin, Grace and Vaid, Shivanshi and Allababidi, Dana and Tessier, Peter M. and Dang, Louis T.},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70500},
url = {https://onlinelibrary.wiley.com/doi/10.1002/acn3.70500?af=R}
}